Christopher Hwang

Chief Technology Officer at Transcenta Therapeutics, Inc

Speaker

Chris has 30+ years of experience in biopharmaceutical industry, specializing in CMC development, tech transfer, and manufacturing. He is currently at Transcenta, responsible for developing and implementing advance biomanufacturing platform to dramatically lower costs, increase agility, and expand patient access to innovative biologics. Prior to joining Transcenta in 2016, he spent 25 years at Genzyme and Sanofi, serving as Senior Director in Late-Stage Process Development and leading the integrated continuous biomanufacturing (ICB) program. He has also been the technical lead for various clinical and commercial stage products. He received his Ph.D. in biochemical engineering from M.I.T.